In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 141-30-0, name is 3,6-Dichloropyridazine, introducing its new discovery. Quality Control of 3,6-Dichloropyridazine
Substituted pyridazinone compounds (by machine translation)
The present invention provides a substituted pyridazinone compound of the pharmaceutical composition and its use, the substituted pyridazinone compound of the formula (I) compounds, or their pharmaceutically acceptable salt, prodrug, hydrate or compound solvent, crystal forms, or stereoisomers or isotopic variants. Compounds of the invention are THR – beta agonists, can be used for treating and/or preventing by the thyroid hormone analogs disorders. (by machine translation)
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 141-30-0, and how the biochemistry of the body works.Quality Control of 3,6-Dichloropyridazine
Reference£º
Pyridazine – Wikipedia,
Pyridazine | C4H4N1550 – PubChem